Answers are grounded in this paper and cite their sources.
Huntington’s Disease (HD) is an autosomal dominant neurodegenerative illness resulting from CAG trinucleotide repeat expansion in the Huntingtin (Htt) gene with a progressive course affecting motor, cognitive and affective domains. This disease has a progressive nature and the outcomes are fully serious motor disorders, psychotic symptoms and death. As for the disease, its spread is rated differently worldwide and the highest rates were identified in Europe and North America. As of now, there is really no cure, which is why investigators embark on the consideration of cure alternatives. Such approach includes use of plant extracts whereby the compounds used are from the members of mint family particularly Mentha spicata; scientifically proven to have medicinal value. This study looks at the prospect of spearmint in relation to therapy for those suffering from HD based on the plant’s antibacterial and antioxidant characteristics. In addition, molecular docking analysis is employed examining the prospects of drug delivery by symptomatically acting peptides like Exendin-4 interacting with the Htt protein to address the issues of mutant protein aggregation. Some of the neuroprotective properties of the peptide Exendin-4 have been demonstrated in an antic diabetes context for the enhancement of motor function to alleviate HD symptoms in animal models. We strongly argue for future studies exploring surviving phytochemical + peptide combinations in the context of Huntington’s disease, as this work reveals important, hitherto uninvestigated aspects of the molecular pathology of this condition.
No takes yet. Share an insight, caveat, or question.
V. Swabna (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: